Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.75 |
| ▸ | GNAI3 | P08754 | 6/20 | 0.59 |
| ▸ | GNAO1 | P09471 | 6/20 | 0.59 |
| ▸ | GNAI1 | P63096 | 6/20 | 0.59 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8266617 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL1277095 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL17833015 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL11207298 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL11486347 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL23682856 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL11210615 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL27096 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL22151380 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H | |
| SCHEMBL19275133 | 1.00 | HRH3 (0.75) | HRH3GNAI3GNAO1GNAI1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024212960-A1 | ANTI-TROP2 ANTIBODY-NATURAL KILLER CELL CONJUGATE AND USE THEREOF | 英百瑞(杭州)生物医药有限公司 | 2024-10-17 | — | — | WO | disclosed |
| WO-2024140904-A1 | ANTI-5T4 ANTIBODY-NATURAL KILLER CELL CONJUGATE AND USE THEREOF | 英百瑞(杭州)生物医药有限公司 | 2024-07-04 | — | — | WO | disclosed |
| EP-3229811-B1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | GRI BIO INC (US) | 2021-02-24 | — | — | EP | disclosed |
| US-4220764-A | Preparation of tertiary heterocyclic amines | UOP INC. (US) | 1980-09-02 | — | — | US | disclosed |